Cargando…
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
Autores principales: | De Franceschi, Lucia, Costa, Enrico, Dima, Francesco, Morandi, Matteo, Olivieri, Oliviero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425710/ https://www.ncbi.nlm.nih.gov/pubmed/32819797 http://dx.doi.org/10.1016/j.ejim.2020.08.015 |
Ejemplares similares
-
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury
por: De Franceschi, Lucia, et al.
Publicado: (2020) -
Fulminant hemolysis in glucose‐6‐phosphate dehydrogenase deficiency
por: Moiz, Bushra, et al.
Publicado: (2017) -
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020) -
Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection – a critical appraisal
por: Afra, T.P., et al.
Publicado: (2020) -
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency
por: Sharma, Dhruva, et al.
Publicado: (2018)